Zobrazeno 101 - 110
of 199
pro vyhledávání: '"63"'
Autor:
Stefan D. Anker, Nicolas Danchin, Gabriel Cristian, Bridget Anne Kirwan, Gerasimos Filippatos, Massimo Piredda, Dinu Dragomir, Robert D. Dowling, Andrew J.S. Coats, Jean-Louis Mas, Maurizio Volterrani, Hani N. Sabbah, Andrew G. Hinson, Scott D. Solomon, Enrico Pusineri, Randall J. Lee, Luca Bettari, Douglas L. Mann, Frank Ahmann
Publikováno v:
European Heart Journal
Aims AUGMENT-HF was an international, multi-centre, prospective, randomized, controlled trial to evaluate the benefits and safety of a novel method of left ventricular (LV) modification with alginate-hydrogel. Methods Alginate-hydrogel is an inert pe
Autor:
Hiroshi Tada, Hiroyasu Iso, Nobuyuki Murakoshi, Fujiko Irie, Miyako Igarashi, Takuji Tomizawa, Hitoshi Ota, Toshimi Sairenchi, Kazutaka Aonuma, Yukio Sekiguchi, Kazumasa Yamagishi, Iwao Yamaguchi, Dongzhu Xu
Publikováno v:
European Heart Journal. 36:170-178
Aims The long-term prognosis of subjects with supraventricular premature complexes (SVPCs) remains unclear in the general population. The aim of this study was to examine the prognostic significance of SVPCs in community-based health checkups. Method
Autor:
João Pedro Ferreira, Faiez Zannad
Publikováno v:
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2016, 37 (41), pp.3175-3177. ⟨10.1093/eurheartj/ehw326⟩
European Heart Journal, Oxford University Press (OUP), 2016, 37 (41), pp.3175-3177. ⟨10.1093/eurheartj/ehw326⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2016, 37 (41), pp.3175-3177. ⟨10.1093/eurheartj/ehw326⟩
European Heart Journal, Oxford University Press (OUP), 2016, 37 (41), pp.3175-3177. ⟨10.1093/eurheartj/ehw326⟩
Aims The globalization of clinical trials has highlighted geographic variations in patient characteristics, event rates, and treatment effects. We investigated these further in PARADIGM-HF, the largest and most globally representative trial in heart
Autor:
Johannes Schwab, Dominik Berliner, Michael Böhm, Verena Stangl, Marziel Schwarzkopf, Philipp Ehlermann, Annegret Franke, Uwe Kühl, Karen Sliwa, Johann Bauersachs, Arash Haghikia, Edith Podewski, Dieter Fischer, Christiane E. Angermann, Ingrid Kindermann, Guido Michels, Denise Hilfiker-Kleiner, Roman Pfister, Ralf Westenfeld, Jens Vogel-Claussen, Axel Schlitt
Publikováno v:
European Heart Journal
Aims An anti-angiogenic cleaved prolactin fragment is considered causal for peripartum cardiomyopathy (PPCM). Experimental and first clinical observations suggested beneficial effects of the prolactin release inhibitor bromocriptine in PPCM. ........
Autor:
Nathaniel M. Hawkins, Nikki Earle, Robert N. Doughty, Pardeep S. Jhund, Cono Ariti, Roy S. Gardner, John J.V. McMurray, Gillian A. Whalley, Katrina Poppe, Iain B. Squire, Mark C. Petrie, Chih M. Wong
Publikováno v:
European Heart Journal. 35:2714-2721
Aim: Our understanding of heart failure in younger patients is limited. The Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) database, which consisted of 24 prospective observational studies and 7 randomized trials, was used to investigat
Autor:
William G. Stevenson, Roy M. John
Publikováno v:
European Heart Journal. 36:145-147
This editorial refers to ‘Prognostic impact of supraventricular premature complexes in community-based health checkups: the Ibaraki Prefectural Health Study’, by N. Murakoshi et al ., on page doi: 10.1093/eurheartj/ehu407 Atrial fibrillation (AF)
Autor:
Stephan Windecker, Tim Kacprowski, Lorenz Räber, Milosz Jaguszewski, Nicolas Rodondi, François Mach, Ulf Landmesser, David Nanchen, Uwe Völker, Philipp Jakob, Pierre Vogt, Roland Klingenberg, Christian M. Matter, Barbara E. Stähli, Dik Heg, Sylvie Briand-Schumacher, Thomas F. Lüscher
Publikováno v:
European Heart Journal, Vol. 38/7 (2017) pp. 511-515
Jakob, Philipp; Kacprowski, Tim; Briand-Schumacher, Sylvie; Heg, Dik; Klingenberg, Roland; Stähli, Barbara E; Jaguszewski, Milosz; Rodondi, Nicolas; Nanchen, David; Räber, Lorenz; Vogt, Pierre; Mach, Francois; Windecker, Stephan; Völker, Uwe; Matter, Christian M; Lüscher, Thomas F; Landmesser, Ulf (2017). Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction. European Heart Journal, 38(7), pp. 511-5. Oxford University Press 10.1093/eurheartj/ehw563
Jakob, Philipp; Kacprowski, Tim; Briand-Schumacher, Sylvie; Heg, Dik; Klingenberg, Roland; Stähli, Barbara E; Jaguszewski, Milosz; Rodondi, Nicolas; Nanchen, David; Räber, Lorenz; Vogt, Pierre; Mach, Francois; Windecker, Stephan; Völker, Uwe; Matter, Christian M; Lüscher, Thomas F; Landmesser, Ulf (2017). Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction. European Heart Journal, 38(7), pp. 511-5. Oxford University Press 10.1093/eurheartj/ehw563
Aims MicroRNAs (miRNA) are important non-coding modulators controlling patterns of gene expression. However, profiling and validation of circulating miRNA levels related to adverse cardiovascular outcome has not been performed in patients with an acu
Autor:
Bernard J. Gersh, Doan T.M. Ngo, Aaron L. Sverdlov, John D. Horowitz, Yuliy Y. Chirkov, Wai P.A. Chan, John J McNeil
Publikováno v:
European Heart Journal. 33:2419-2425
Aims Aortic valve stenosis (AS) and its precursor, aortic valve sclerosis (ASc), occur frequently in Western populations. Investigations to retard the progression of AS using statins have been unsuccessful. Development of ASc in humans is associated
Autor:
Vasileia Varvarigou, Mei Chung, Georgios D Kitsios, Radley C. Sheldrick, Haseeb Jafri, Jessica K. Paulus, Issa J Dahabreh, Thomas A Trikalinos, Jeremy A. Rassen
Publikováno v:
European Heart Journal. 33:1893-1901
Aims Randomized controlled trials (RCTs) are the gold standard for assessing the efficacy of therapeutic interventions because randomization protects from biases inherent in observational studies. Propensity score (PS) methods, proposed as a potentia
Autor:
Jennifer H. Pinney, Prayman T. Sattianayagam, Arie J. Stangou, Philip N. Hawkins, Carol J. Whelan, Helen J. Lachmann, Ashutosh D. Wechalekar, Simon D. J. Gibbs, Peter W. Pflugfelder, Zoe Fox, Angelika F Hahn, Dorota Rowczenio, Julian D. Gillmore
Publikováno v:
European Heart Journal. 33:1120-1127
Aims Familial amyloid polyneuropathy (FAP) is a dominantly inherited multi-system disease associated with transthyretin (TTR) mutations. Previous series have predominantly described patients with the TTR variant Val30Met (V30M), which is the most pre